Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6C7Y

Crystal structure of inhibitory protein SOCS1 in complex with JAK1 kinase domain

Summary for 6C7Y
Entry DOI10.2210/pdb6c7y/pdb
Related6C5X
DescriptorTyrosine-protein kinase JAK1, Suppressor of cytokine signaling 1, ADENOSINE-5'-DIPHOSPHATE, ... (7 entities in total)
Functional Keywordskinase, kinase inhibitor, signaling protein, transferase-inhibitor complex, transferase/inhibitor
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight46822.74
Authors
Liau, N.P.D.,Laktyushin, A.,Lucet, I.S.,Murphy, J.M.,Yao, S.,Callaghan, K.,Nicola, N.A.,Kershaw, N.J.,Babon, J.J. (deposition date: 2018-01-23, release date: 2018-05-02, Last modification date: 2024-11-13)
Primary citationLiau, N.P.D.,Laktyushin, A.,Lucet, I.S.,Murphy, J.M.,Yao, S.,Whitlock, E.,Callaghan, K.,Nicola, N.A.,Kershaw, N.J.,Babon, J.J.
The molecular basis of JAK/STAT inhibition by SOCS1.
Nat Commun, 9:1558-1558, 2018
Cited by
PubMed Abstract: The SOCS family of proteins are negative-feedback inhibitors of signalling induced by cytokines that act via the JAK/STAT pathway. SOCS proteins can act as ubiquitin ligases by recruiting Cullin5 to ubiquitinate signalling components; however, SOCS1, the most potent member of the family, can also inhibit JAK directly. Here we determine the structural basis of both these modes of inhibition. Due to alterations within the SOCS box domain, SOCS1 has a compromised ability to recruit Cullin5; however, it is a direct, potent and selective inhibitor of JAK catalytic activity. The kinase inhibitory region of SOCS1 targets the substrate binding groove of JAK with high specificity and thereby blocks any subsequent phosphorylation. SOCS1 is a potent inhibitor of the interferon gamma (IFNγ) pathway, however, it does not bind the IFNγ receptor, making its mode-of-action distinct from SOCS3. These findings reveal the mechanism used by SOCS1 to inhibit signalling by inflammatory cytokines.
PubMed: 29674694
DOI: 10.1038/s41467-018-04013-1
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.499 Å)
Structure validation

234136

건을2025-04-02부터공개중

PDB statisticsPDBj update infoContact PDBjnumon